| EC/E.cava | Ecklonia cava |
| ECE | Ecklonia cava extract |
| NC | normal control |
| PC | positive control |
| HFD | high-fat diet |
| T1 | low dose of ECE treatment group |
| T2 | intermediate dose of ECE treatment group |
| T3 | high dose of ECE treatment group |
| HCA | hydroxy citric acid |
| BW/b.w | bodyweight |
| FCR | feed conversion rate |
| GIP | gastric inhibitory peptides |
| GGT | gamma-glutamyl transferase |
| LDL | low-density lipoprotein |
| HDL | high-density lipoprotein |
| TG | triglycerides |
| FFA | free fatty acid |
| AI | atherogenic index |
| RNA | ribonucleic Acid |
| PCR | polymerase chain reaction |
| CDNA | complementary DNA |
| DMEM | Dulbecco’s modified Eagle’s medium |
| PPAR-γ | peroxisome proliferator-activated receptor gamma |
| LPL | lipo-protein lipase |
| SRBP-1c | sterol regulatory element-binding transcription factor 1 |
| FBS | fetus bovine serum |
| DEX | dexamethasone |
| IBMX | 3-Isobutyl-1-methylxanthine |
| ROC | receiver operating characteristics |
| AUROC | area under receiver operating characteristics curve |
| ALP | alkaline phosphatase |
| ALT | alanine transaminase |
| AST | aspartate transaminase |
| GGT | gamma-glutamyl-transferase |
| WHO | World Health Organization |
| COVID | coronavirus disease |
| NAFLD | nonalcoholic fatty liver disease |
| HIV | human immunodeficiency virus |
| SD | Sprague–Dawley |
| DCM | dichloromethane |
| IU | international unit |
| PBS | Phospahte buffer saline |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| DMSO | dimethyl sulfoxide |
| OD | optical density |
| DPPH | 2,2-diphenyl-1picryl-hydrzyl |
| ABTS | 2,2-azino-bis(3-ethylbenzothiazolin)-6-sulfonic acid |
| RPM | round per minute |
| TA | tannic acid |
| FF | fenofibrate |
| SEM | standard error mean |
| ELISA | enzyme-linked immunoassay |
| TNF-a | tumor necrosis factor-alpha |
| IL-6 | interleukin-6 |